Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Shirking, sharing risk and shelving: The role of university license contracts

16 references·16 citing·43 second hopsampled

FromToDepth

this work references cited by second hop· second hop is a sample of the most-cited connections

References

2000Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)3,045 cited
1982Preemptive Patenting and the Persistence of Monopoly1,351 cited
1994The Management of Innovation1,232 cited
2001Proofs and Prototypes for Sale: The Licensing of University Inventions1,164 cited
2002Who Is Selling the Ivory Tower? Sources of Growth in University Licensing850 cited
2001Objectives, Characteristics and Outcomes of University Licensing: A Survey of Major U.S. Universities712 cited
1985On the Licensing of Innovations609 cited
2002Markets for Technology: The Economics of Innovation and Corporate StrategyMarkets for Technology: The Economics of Innovation and Corporate Strategy, by AroraAshish FosfuriAndrea, and GambardellaAlfonso. Cambridge, MA: MIT Press, 2001.565 cited
2000The Structure of Licensing Contracts548 cited
2001University‐to‐industry knowledge transfer: literature review and unanswered questions546 cited
1990Technology Transfer under Asymmetric Information490 cited
2002Equity and the Technology Transfer Strategies of American Research Universities430 cited
2009Innovation and Economic Growth367 cited
1992The Economics of Uncertainty and Information.365 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2003Disclosure and licensing of University inventions: ‘The best we can do with the s**t we get to work with’353 cited

1984Deterrence by Market Sharing: A Strategic Incentive for Licensing327 cited

Cited by

2014Decoding the Adaptability–Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies150 cited
2008Licensing Strategies of the New “Intellectual Property Vendors”75 cited
2016Licensing Contracts: Control Rights, Options, and Timing73 cited
2014The Role of Equity, Royalty, and Fixed Fees in Technology Licensing to University Spin-Offs71 cited
2010Inventor moral hazard in university licensing: The role of contracts71 cited
2008Negative effects of university patenting: Myths and grounded evidence69 cited
2017Experience and Signaling Value in Technology Licensing Contract Payment Structures59 cited
2011University-industry linkages in nanotechnology and biotechnology: evidence on collaborative patterns for new methods of inventing58 cited
2013Opt‐Out Options in New Product Co‐development Partnerships58 cited
2011Commercialization, Renewal and Quality of Patents56 cited
2010Incentives in university technology transfers56 cited
2015Individual versus Institutional Ownership of University-Discovered Inventions47 cited
2012We need to talk – or do we? Geographic distance and the commercialization of technologies from public research40 cited
2014Tacit Knowledge and the Structure of License Contracts: Evidence from the Biomedical Industry39 cited
2015Faculty patent assignment in the Chinese mainland: evidence from the top 35 patent application universities32 cited
2014Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation32 cited